Novilla Pharmaceuticals
Pre-clinicalNovilla’s first drug candidate designed by our proprietary AI Algorithim, NOV-1776, recently finished human clinical trials showing a 212% increase in efficacy over the standard of care with <1% systemic exposure and 0% GI AEs
Founded
2017
Focus
Drug Delivery
About
Novilla’s first drug candidate designed by our proprietary AI Algorithim, NOV-1776, recently finished human clinical trials showing a 212% increase in efficacy over the standard of care with <1% systemic exposure and 0% GI AEs
Company Info
TypePrivate
Founded2017
LocationPrinceton, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile